Foveal Thickness between Stratus and Spectralis Optical Coherence Tomography in Retinal Diseases.
10.3341/kjo.2013.27.4.268
- Author:
Young Rae ROH
1
;
Kyu Hyung PARK
;
Se Joon WOO
Author Information
1. Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. sejoon1@snu.ac.kr
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Foveal thickness;
Optical coherence tomography;
Prediction;
Spectral-domain;
Time-domain
- MeSH:
Adolescent;
Adult;
Aged;
Aged, 80 and over;
Cross-Sectional Studies;
Female;
Fovea Centralis/*pathology;
Humans;
Male;
Middle Aged;
Predictive Value of Tests;
Retinal Diseases/*pathology;
Retrospective Studies;
*Tomography, Optical Coherence;
Young Adult
- From:Korean Journal of Ophthalmology
2013;27(4):268-275
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: To compare the foveal thickness (FT) parameters measured by Stratus optical coherence tomography (OCT) and Spectralis OCT in various retinal diseases and to construct conversion formulas between the two types of OCT devices. METHODS: We examined 366 consecutive patients (475 eyes) with retinal diseases and 13 normal controls (13 eyes). The patients were categorized into eight retinal disease groups. The mean amount and distribution of foveal thickness differences (FTD) measured by Stratus and Spectralis OCT were determined, and conversion formulas were constructed for Stratus OCT FT from Spectralis OCT FT for each retinal disease group. RESULTS: Among retinal diseases, the mean FTD was significantly larger in exudative age-related macular degeneration (AMD) patients (mean +/- SD, 94.0 +/- 55.0 microm) compared to normal subjects (66.2 +/- 11.7 microm; p < 0.0001). The proportion of eyes with a mean FTD outside 1.96 standard deviations of normal subject FTD was greatest in the exudative AMD (50.0%) group and smallest in the macular hole (18.2%) group. The predicted FTs obtained through the conversion formulas showed lower variance than the actual FTD values, especially in the exudative AMD group. The prediction line for exudative AMD deviated most from that of normal subjects. CONCLUSIONS: FTD shows diverse values and variances among various retinal diseases, especially in exudative AMD, which indicates that Stratus OCT FT cannot be predicted from Spectralis OCT FT by FTD value alone. We constructed statistically significant conversion formulas, which provided more reliable methods to predict Stratus OCT-measured FT from Spectralis OCT measurements for different retinal disease groups.
